We are live on ! Find out more
Brown Advisory

Brown Advisory Portfolio holdings

AUM $60.9B
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+29.07%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$42.9B
AUM Growth
+$10.3B
Cap. Flow
+$1.58B
Cap. Flow %
3.68%
Top 10 Hldgs %
25.79%
Holding
1,005
New
68
Increased
375
Reduced
381
Closed
51

Top Buys

Rank Stock Value
1
LULU icon
lululemon athletica
LULU
+$367M
2
G icon
Genpact
G
+$111M
3
INTU icon
Intuit
INTU
+$106M
4
DHR icon
Danaher
DHR
+$96.6M
5
V icon
Visa
V
+$79.2M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$259M
2
DXCM icon
DexCom
DXCM
+$152M
3
SBAC icon
SBA Communications
SBAC
+$59.5M
4
BABA icon
Alibaba
BABA
+$51.6M
5
JPM icon
JPMorgan Chase
JPM
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 26.17%
2 Healthcare 19.02%
3 Financials 11.9%
4 Consumer Discretionary 11.2%
5 Industrials 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
926
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$71K ﹤0.01%
19,483
+107
+0.6% +$386
NYMX
927
DELISTED
Nymox Pharmaceutical Corp
NYMX
$66K ﹤0.01%
18,700
AR icon
928
Antero Resources
AR
$10.9B
$61K ﹤0.01%
23,819
AM icon
929
Antero Midstream
AM
$10.8B
$51K ﹤0.01%
+10,000
New +$44.3K
BBVA icon
930
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$51K ﹤0.01%
14,968
+700
+5% +$2.21K
MACK
931
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$50K ﹤0.01%
15,029
GOGO icon
932
Gogo Inc
GOGO
$515M
$41K ﹤0.01%
13,006
CX icon
933
Cemex
CX
$17.4B
$37K ﹤0.01%
+12,688
New +$29.8K
ADIL
934
Adial Pharmaceuticals
ADIL
$6.08M
$36K ﹤0.01%
42
LYG icon
935
Lloyds Banking Group
LYG
$87.4B
$29K ﹤0.01%
19,247
+3,618
+23% +$5.43K
SAN icon
936
Banco Santander
SAN
$194B
$27K ﹤0.01%
11,774
+107
+0.9% +$234
UUUU icon
937
Energy Fuels
UUUU
$2.82B
$25K ﹤0.01%
16,500
AIG.WS
938
DELISTED
American International Group, Inc.
AIG.WS
$22K ﹤0.01%
15,489
+10
+0.1% +$12
AQMS icon
939
Aqua Metals
AQMS
$9.63M
$20K ﹤0.01%
73
NVAX icon
940
PUT
Novavax
NVAX
$1.23B
$16K ﹤0.01%
+4,700
New +$180K
BRK.B icon
941
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
$13K ﹤0.01%
+1,300
New +$237K
CVEO icon
942
Civeo
CVEO
$379M
$12K ﹤0.01%
1,607
AMPE
943
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$11K ﹤0.01%
56
ZM icon
944
PUT
Zoom
ZM
$25.8B
$10K ﹤0.01%
+8,100
New +$1.46M
DNR
945
DELISTED
Denbury Resources, Inc.
DNR
$10K ﹤0.01%
36,000
BABA icon
946
CALL
Alibaba
BABA
$269B
$8K ﹤0.01%
+1,200
New +$250K
OIG
947
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$8K ﹤0.01%
312
BA icon
948
CALL
Boeing
BA
$165B
$7K ﹤0.01%
+200
New +$30.7K
SENS icon
949
Senseonics Holdings Inc
SENS
$254M
$4K ﹤0.01%
500
SBUX icon
950
CALL
Starbucks
SBUX
$118B
$2K ﹤0.01%
+300
New +$22.5K

Similar funds

Brown Advisory's Q2 2020 Portfolio in Review

As of Q2 2020, Brown Advisory held 1,005 positions worth $42.9B, up 32% from $32.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Brown Advisory deployed $1.58B of net new capital in Q2 2020, opening 68 new positions and adding to 375 existing holdings. Its largest new stake was lululemon athletica: 1,436,824 shares worth $448M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was TJX Companies, an estimated $259M trimmed.

  • Brown Advisory's largest Q2 2020 buy was lululemon athletica: 1,436,824 shares worth $448M.
  • Brown Advisory added most to Genpact in Q2 2020, an estimated $111M increase.
  • Brown Advisory's biggest Q2 2020 reduction was TJX Companies, cutting an estimated $259M.
  • Brown Advisory fully exited Deluxe in Q2 2020, selling an estimated $16.8M.
  • Brown Advisory's ten largest holdings make up 26% of its $42.9B portfolio in Q2 2020.
  • Brown Advisory opened 68 new positions and closed 51 in Q2 2020.
  • Brown Advisory's portfolio value rose 32% quarter-over-quarter to $42.9B.

Based on Brown Advisory's 13F filing for Q2 2020, filed 14 Aug 2020.